Combining Treatment Components in Transdiagnostic Therapy for Anxiety and Depression
Launched by UNIVERSITY OF AARHUS · May 22, 2024
Trial Information
Current as of February 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to treat anxiety and depression by combining two types of therapy techniques: cognitive restructuring and detached mindfulness. These techniques are part of cognitive behavioral therapy (CBT), which helps people change negative thinking patterns and become more aware of their thoughts. The goal of this study is to see how well these approaches work both separately and together, and to find out which patients benefit the most from this combination.
To participate in this trial, you need to be at least 18 years old and have a diagnosis of an anxiety disorder (like generalized anxiety or panic disorder) or mild to moderate depression. You should also be comfortable speaking Danish and have access to a device like a smartphone or computer for online sessions. Participants will receive therapy through a video platform, and the study aims to help researchers understand the best ways to treat these common mental health conditions. If you or someone you know is interested, this could be a great opportunity to contribute to important research while receiving support for anxiety or depression.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 18 years.
- • 2. A diagnosis of an anxiety disorder (generalized anxiety disorder, social anxiety disorder, or panic disorder with or without agoraphobia) and/or mild to moderate major depressive disorder (MDD) according to DSM-5 (American Psychiatric Association, 2022).
- • 3. Danish language proficiency.
- • 4. Ability and willingness to give informed consent.
- • 5. No or stable antidepressant/antianxiety medication (i.e., same dosage for ≥ 8 weeks).
- • 6. Access to either a smartphone, tablet, or computer with video camera.
- Exclusion Criteria:
- • 1. Severe depression deemed to require more intense psychotherapy or medication.
- • 2. Persistent depressive disorder (i.e., depressive symptoms have persisted for 2 years or more).
- • 3. Non-stabilized medication (see above).
- • 4. Currently receiving other psychotherapy or counseling.
- • 5. Not capable of participating online.
- • 6. Lack of Danish proficiency.
- • 7. A history of bipolar disorder.
- • 8. Current or past psychosis.
- • 9. Substance abuse or dependence judged to require treatment.
- • 10. Suicide risk requiring immediate hospitalization.
Trial Officials
Caroline Nørskov, MSc
Principal Investigator
University of Aarhus
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0